Mydecine Innovations Group Inc. (OTCMKTS:MYCOF – Get Rating)'s stock price traded up 2.6% during mid-day trading on Monday . The company traded as high as $0.60 and last traded at $0.55. 28,180 shares were traded during mid-day trading, an increase of 56% from the average session volume of 18,021 shares. The stock had previously closed at $0.54.
Mydecine Innovations Group Stock Up 2.6 %
The business's 50 day moving average is $0.65 and its 200-day moving average is $2.26.
Mydecine Innovations Group Company Profile
(Get Rating)
Mydecine Innovations Group Inc, a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services.
Further Reading
- Get a free copy of the StockNews.com research report on Mydecine Innovations Group (MYCOF)
- Three Industrial Stocks That Can Weather a Stormy Recession
- Bed Bath & Beyond Meat: Is BYND the Next Big Short Squeeze?
- Denbury Rises On Rumor Of A Sale, But Lags Other Energy Names
- The Tipping Point is Finally Arriving for Lemonade
- Oil Services: Who Will Lead The Rebound?
Receive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.